Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05987163 · ClinicalTrials.gov registry record · NA
Study to Evaluate the Safety and Effectiveness of GP0116
A NA study of Skin Manifestations, sponsored by Galderma R&D.
- Active
- Registry status
- NA
- Development phase
- 186
- Enrollment target
- 19
- Study locations
NCT05987163 is a NA study of Skin Manifestations that is active but no longer recruiting, run by Galderma R&D. The registered enrollment target is 186 participants. The trial reports 19 study locations across 14 states.
The verdict
NCT05987163, a NA study of Skin Manifestations, is active but no longer recruiting, sponsored by Galderma R&D.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 186 participants
- Enrollment target
- 19
- Study locations
Study Summary
This is a prospective, randomized, evaluator-blinded, comparator-controlled, parallel group, multicenter study in the U.S. for correction of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds (NLFs).
Conditions Studied
Interventions
- DEVICE GP0116
- DEVICE Active Comparator: FDA approved dermal filler device (RHA 3)
Study Locations (19)
Florida
- Galderma Investigational Site (Site#8479) - Bradenton
- Galderma Investigational Site (Site#7030) - Coral Gables
- Galderma Investigational Site (Site#8284) - Coral Gables
- Galderma Investigational Site (Site#8126) - West Palm Beach
California
- Galderma Investigational Site (Site#8074) - Santa Monica
- Galderma Investigational Site (Site#8478) - Vista
North Carolina
- Galderma Investigational Site (Site#8482) - Chapel Hill
- Galderma Investigational Site (Site#8648) - Wilmington
Connecticut
- Galderma Investigational Site (Site#8680) - Westport
Georgia
- Galderma Investigational Site (Site#7042) - Atlanta
Louisiana
- Galderma Investigational Site (Site#8580) - New Orleans
Massachusetts
- Galderma Investigational Site (Site#8481) - Chestnut Hill
Michigan
- Galderma Investigational Site (Site#8631) - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 186 participants |
| Start Date | 2023-04-12 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05987163
The ClinicalTrials.gov registry entry for NCT05987163 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 186 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Skin Manifestations appearing as the primary indexed condition, and to 2 interventions - of which GP0116 is the first listed.
NCT05987163 reports 19 study locations spanning 14 distinct geographic areas - top geographies include Florida, California, North Carolina.
Frequently Asked Questions
What is clinical trial NCT05987163 about?
NCT05987163 is a clinical study titled "Study to Evaluate the Safety and Effectiveness of GP0116". This is a prospective, randomized, evaluator-blinded, comparator-controlled, parallel group, multicenter study in the U.S. for correction of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds (NLFs).
What is the current status of trial NCT05987163?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 186 participants. The study started on 2023-04-12. Estimated completion is 2026-03-31.
What conditions does trial NCT05987163 study?
This clinical trial studies the following conditions: Skin Manifestations.
What interventions are being tested in trial NCT05987163?
The interventions under investigation include: GP0116 (DEVICE), Active Comparator: FDA approved dermal filler device (RHA 3) (DEVICE).
Who is sponsoring clinical trial NCT05987163?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05987163 being conducted?
This trial has 19 study locations across California, Connecticut, Florida, Georgia, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Manifestations
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.